非侵襲的リキッドバイオプシーの世界市場見通し2023年-2029年

◆英語タイトル:Non-Invasive Liquid Biopsy Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書(MMG23FB2210)◆商品コード:MMG23FB2210
◆発行会社(リサーチ会社):Market Monitor Global
◆発行日:2023年2月
◆ページ数:100
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後2-3営業日)
◆調査対象地域:グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,250 ⇒換算¥494,000見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD4,225 ⇒換算¥642,200見積依頼/購入/質問フォーム
Enterprise User(閲覧人数制限なし)USD4,875 ⇒換算¥741,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界の非侵襲的リキッドバイオプシー市場規模と予測を収録しています。・世界の非侵襲的リキッドバイオプシー市場:売上、2018年-2023年、2024年-2029年
・世界の非侵襲的リキッドバイオプシー市場:販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の非侵襲的リキッドバイオプシー市場は2022年に000Mドルと評価され、予測期間中に000%のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「便検査」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

非侵襲的リキッドバイオプシーのグローバル主要企業は、Bio-Techne、Endress+Hauser、Exact Sciences Corporation、Lonza Group AG、MDxHealth、Merck KGaA、MutantDx、Norgen Biotek Corp、Nucleix、Oasis Diagnostics Corporation、OraSure Technologies、PerkinElmer、Predicine、Qiagen、Thermo Fisher Scientific、Zymo Research Corporationなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL(MMG)は、非侵襲的リキッドバイオプシーのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の非侵襲的リキッドバイオプシー市場:タイプ別、2018年-2023年、2024年-2029年
世界の非侵襲的リキッドバイオプシー市場:タイプ別市場シェア、2022年
・便検査、尿検査、唾液検査、その他

世界の非侵襲的リキッドバイオプシー市場:用途別、2018年-2023年、2024年-2029年
世界の非侵襲的リキッドバイオプシー市場:用途別市場シェア、2022年
・病院、研究所、その他

世界の非侵襲的リキッドバイオプシー市場:地域・国別、2018年-2023年、2024年-2029年
世界の非侵襲的リキッドバイオプシー市場:地域別市場シェア、2022年
・北米:アメリカ、カナダ、メキシコ
・ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
・アジア:中国、日本、韓国、東南アジア、インド
・南米:ブラジル、アルゼンチン
・中東・アフリカ:トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における非侵襲的リキッドバイオプシーのグローバル売上、2018年-2023年
・主要企業における非侵襲的リキッドバイオプシーのグローバル売上シェア、2022年
・主要企業における非侵襲的リキッドバイオプシーのグローバル販売量、2018年-2023年
・主要企業における非侵襲的リキッドバイオプシーのグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Bio-Techne、Endress+Hauser、Exact Sciences Corporation、Lonza Group AG、MDxHealth、Merck KGaA、MutantDx、Norgen Biotek Corp、Nucleix、Oasis Diagnostics Corporation、OraSure Technologies、PerkinElmer、Predicine、Qiagen、Thermo Fisher Scientific、Zymo Research Corporation

*************************************************************

・調査・分析レポートの概要
非侵襲的リキッドバイオプシー市場の定義
市場セグメント
世界の非侵襲的リキッドバイオプシー市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の非侵襲的リキッドバイオプシー市場規模
世界の非侵襲的リキッドバイオプシー市場規模:2022年 VS 2029年
世界の非侵襲的リキッドバイオプシー市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの非侵襲的リキッドバイオプシーの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の非侵襲的リキッドバイオプシー製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分:便検査、尿検査、唾液検査、その他
非侵襲的リキッドバイオプシーのタイプ別グローバル売上・予測

・用途別市場分析
用途区分:病院、研究所、その他
非侵襲的リキッドバイオプシーの用途別グローバル売上・予測

・地域別市場分析
地域別非侵襲的リキッドバイオプシー市場規模 2022年と2029年
地域別非侵襲的リキッドバイオプシー売上・予測
北米市場:アメリカ、カナダ、メキシコ
ヨーロッパ市場:ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場:中国、日本、韓国、東南アジア、インド
南米市場:ブラジル、アルゼンチン
中東・アフリカ市場:トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル(企業概要、事業概要、主要製品、売上、ニュースなど)
Bio-Techne、Endress+Hauser、Exact Sciences Corporation、Lonza Group AG、MDxHealth、Merck KGaA、MutantDx、Norgen Biotek Corp、Nucleix、Oasis Diagnostics Corporation、OraSure Technologies、PerkinElmer、Predicine、Qiagen、Thermo Fisher Scientific、Zymo Research Corporation
...

Non-invasive liquid biopsy is to analyze and diagnose diseases such as cancer through blood or urine and other body fluids. At present, the main application area of liquid biopsy is the blood detection of tumors, that is, the use of blood to indicate tumor development and drug resistance and other information to guide individualized and precise treatment. Compared with existing tumor detection methods, liquid biopsy is non-invasive, can be detected frequently and repeatedly, and has rapid response capabilities. It has significant advantages and has great potential for application development.
This report aims to provide a comprehensive presentation of the global market for Non-Invasive Liquid Biopsy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-Invasive Liquid Biopsy. This report contains market size and forecasts of Non-Invasive Liquid Biopsy in global, including the following market information:
Global Non-Invasive Liquid Biopsy Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Non-Invasive Liquid Biopsy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Stool Test Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Non-Invasive Liquid Biopsy include Bio-Techne, Endress+Hauser, Exact Sciences Corporation, Lonza Group AG, MDxHealth, Merck KGaA, MutantDx, Norgen Biotek Corp and Nucleix, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Non-Invasive Liquid Biopsy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
[Total Market by Segment]
Global Non-Invasive Liquid Biopsy Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Non-Invasive Liquid Biopsy Market Segment Percentages, by Type, 2022 (%)
Stool Test
Urine Test
Saliva Test
Others
Global Non-Invasive Liquid Biopsy Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Non-Invasive Liquid Biopsy Market Segment Percentages, by Application, 2022 (%)
Hospital
Laboratory
Others
Global Non-Invasive Liquid Biopsy Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Non-Invasive Liquid Biopsy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Non-Invasive Liquid Biopsy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Non-Invasive Liquid Biopsy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bio-Techne
Endress+Hauser
Exact Sciences Corporation
Lonza Group AG
MDxHealth
Merck KGaA
MutantDx
Norgen Biotek Corp
Nucleix
Oasis Diagnostics Corporation
OraSure Technologies
PerkinElmer
Predicine
Qiagen
Thermo Fisher Scientific
Zymo Research Corporation
Outline of Major Chapters:
Chapter 1: Introduces the definition of Non-Invasive Liquid Biopsy, market overview.
Chapter 2: Global Non-Invasive Liquid Biopsy market size in revenue.
Chapter 3: Detailed analysis of Non-Invasive Liquid Biopsy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Non-Invasive Liquid Biopsy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Non-Invasive Liquid Biopsy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Non-Invasive Liquid Biopsy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Non-Invasive Liquid Biopsy Overall Market Size
2.1 Global Non-Invasive Liquid Biopsy Market Size: 2022 VS 2029
2.2 Global Non-Invasive Liquid Biopsy Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Non-Invasive Liquid Biopsy Players in Global Market
3.2 Top Global Non-Invasive Liquid Biopsy Companies Ranked by Revenue
3.3 Global Non-Invasive Liquid Biopsy Revenue by Companies
3.4 Top 3 and Top 5 Non-Invasive Liquid Biopsy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Non-Invasive Liquid Biopsy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Non-Invasive Liquid Biopsy Players in Global Market
3.6.1 List of Global Tier 1 Non-Invasive Liquid Biopsy Companies
3.6.2 List of Global Tier 2 and Tier 3 Non-Invasive Liquid Biopsy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Non-Invasive Liquid Biopsy Market Size Markets, 2022 & 2029
4.1.2 Stool Test
4.1.3 Urine Test
4.1.4 Saliva Test
4.1.5 Others
4.2 By Type – Global Non-Invasive Liquid Biopsy Revenue & Forecasts
4.2.1 By Type – Global Non-Invasive Liquid Biopsy Revenue, 2018-2023
4.2.2 By Type – Global Non-Invasive Liquid Biopsy Revenue, 2024-2029
4.2.3 By Type – Global Non-Invasive Liquid Biopsy Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Non-Invasive Liquid Biopsy Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Laboratory
5.1.4 Others
5.2 By Application – Global Non-Invasive Liquid Biopsy Revenue & Forecasts
5.2.1 By Application – Global Non-Invasive Liquid Biopsy Revenue, 2018-2023
5.2.2 By Application – Global Non-Invasive Liquid Biopsy Revenue, 2024-2029
5.2.3 By Application – Global Non-Invasive Liquid Biopsy Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Non-Invasive Liquid Biopsy Market Size, 2022 & 2029
6.2 By Region – Global Non-Invasive Liquid Biopsy Revenue & Forecasts
6.2.1 By Region – Global Non-Invasive Liquid Biopsy Revenue, 2018-2023
6.2.2 By Region – Global Non-Invasive Liquid Biopsy Revenue, 2024-2029
6.2.3 By Region – Global Non-Invasive Liquid Biopsy Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Non-Invasive Liquid Biopsy Revenue, 2018-2029
6.3.2 US Non-Invasive Liquid Biopsy Market Size, 2018-2029
6.3.3 Canada Non-Invasive Liquid Biopsy Market Size, 2018-2029
6.3.4 Mexico Non-Invasive Liquid Biopsy Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Non-Invasive Liquid Biopsy Revenue, 2018-2029
6.4.2 Germany Non-Invasive Liquid Biopsy Market Size, 2018-2029
6.4.3 France Non-Invasive Liquid Biopsy Market Size, 2018-2029
6.4.4 U.K. Non-Invasive Liquid Biopsy Market Size, 2018-2029
6.4.5 Italy Non-Invasive Liquid Biopsy Market Size, 2018-2029
6.4.6 Russia Non-Invasive Liquid Biopsy Market Size, 2018-2029
6.4.7 Nordic Countries Non-Invasive Liquid Biopsy Market Size, 2018-2029
6.4.8 Benelux Non-Invasive Liquid Biopsy Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Non-Invasive Liquid Biopsy Revenue, 2018-2029
6.5.2 China Non-Invasive Liquid Biopsy Market Size, 2018-2029
6.5.3 Japan Non-Invasive Liquid Biopsy Market Size, 2018-2029
6.5.4 South Korea Non-Invasive Liquid Biopsy Market Size, 2018-2029
6.5.5 Southeast Asia Non-Invasive Liquid Biopsy Market Size, 2018-2029
6.5.6 India Non-Invasive Liquid Biopsy Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Non-Invasive Liquid Biopsy Revenue, 2018-2029
6.6.2 Brazil Non-Invasive Liquid Biopsy Market Size, 2018-2029
6.6.3 Argentina Non-Invasive Liquid Biopsy Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Non-Invasive Liquid Biopsy Revenue, 2018-2029
6.7.2 Turkey Non-Invasive Liquid Biopsy Market Size, 2018-2029
6.7.3 Israel Non-Invasive Liquid Biopsy Market Size, 2018-2029
6.7.4 Saudi Arabia Non-Invasive Liquid Biopsy Market Size, 2018-2029
6.7.5 UAE Non-Invasive Liquid Biopsy Market Size, 2018-2029
7 Non-Invasive Liquid Biopsy Companies Profiles
7.1 Bio-Techne
7.1.1 Bio-Techne Company Summary
7.1.2 Bio-Techne Business Overview
7.1.3 Bio-Techne Non-Invasive Liquid Biopsy Major Product Offerings
7.1.4 Bio-Techne Non-Invasive Liquid Biopsy Revenue in Global Market (2018-2023)
7.1.5 Bio-Techne Key News & Latest Developments
7.2 Endress+Hauser
7.2.1 Endress+Hauser Company Summary
7.2.2 Endress+Hauser Business Overview
7.2.3 Endress+Hauser Non-Invasive Liquid Biopsy Major Product Offerings
7.2.4 Endress+Hauser Non-Invasive Liquid Biopsy Revenue in Global Market (2018-2023)
7.2.5 Endress+Hauser Key News & Latest Developments
7.3 Exact Sciences Corporation
7.3.1 Exact Sciences Corporation Company Summary
7.3.2 Exact Sciences Corporation Business Overview
7.3.3 Exact Sciences Corporation Non-Invasive Liquid Biopsy Major Product Offerings
7.3.4 Exact Sciences Corporation Non-Invasive Liquid Biopsy Revenue in Global Market (2018-2023)
7.3.5 Exact Sciences Corporation Key News & Latest Developments
7.4 Lonza Group AG
7.4.1 Lonza Group AG Company Summary
7.4.2 Lonza Group AG Business Overview
7.4.3 Lonza Group AG Non-Invasive Liquid Biopsy Major Product Offerings
7.4.4 Lonza Group AG Non-Invasive Liquid Biopsy Revenue in Global Market (2018-2023)
7.4.5 Lonza Group AG Key News & Latest Developments
7.5 MDxHealth
7.5.1 MDxHealth Company Summary
7.5.2 MDxHealth Business Overview
7.5.3 MDxHealth Non-Invasive Liquid Biopsy Major Product Offerings
7.5.4 MDxHealth Non-Invasive Liquid Biopsy Revenue in Global Market (2018-2023)
7.5.5 MDxHealth Key News & Latest Developments
7.6 Merck KGaA
7.6.1 Merck KGaA Company Summary
7.6.2 Merck KGaA Business Overview
7.6.3 Merck KGaA Non-Invasive Liquid Biopsy Major Product Offerings
7.6.4 Merck KGaA Non-Invasive Liquid Biopsy Revenue in Global Market (2018-2023)
7.6.5 Merck KGaA Key News & Latest Developments
7.7 MutantDx
7.7.1 MutantDx Company Summary
7.7.2 MutantDx Business Overview
7.7.3 MutantDx Non-Invasive Liquid Biopsy Major Product Offerings
7.7.4 MutantDx Non-Invasive Liquid Biopsy Revenue in Global Market (2018-2023)
7.7.5 MutantDx Key News & Latest Developments
7.8 Norgen Biotek Corp
7.8.1 Norgen Biotek Corp Company Summary
7.8.2 Norgen Biotek Corp Business Overview
7.8.3 Norgen Biotek Corp Non-Invasive Liquid Biopsy Major Product Offerings
7.8.4 Norgen Biotek Corp Non-Invasive Liquid Biopsy Revenue in Global Market (2018-2023)
7.8.5 Norgen Biotek Corp Key News & Latest Developments
7.9 Nucleix
7.9.1 Nucleix Company Summary
7.9.2 Nucleix Business Overview
7.9.3 Nucleix Non-Invasive Liquid Biopsy Major Product Offerings
7.9.4 Nucleix Non-Invasive Liquid Biopsy Revenue in Global Market (2018-2023)
7.9.5 Nucleix Key News & Latest Developments
7.10 Oasis Diagnostics Corporation
7.10.1 Oasis Diagnostics Corporation Company Summary
7.10.2 Oasis Diagnostics Corporation Business Overview
7.10.3 Oasis Diagnostics Corporation Non-Invasive Liquid Biopsy Major Product Offerings
7.10.4 Oasis Diagnostics Corporation Non-Invasive Liquid Biopsy Revenue in Global Market (2018-2023)
7.10.5 Oasis Diagnostics Corporation Key News & Latest Developments
7.11 OraSure Technologies
7.11.1 OraSure Technologies Company Summary
7.11.2 OraSure Technologies Business Overview
7.11.3 OraSure Technologies Non-Invasive Liquid Biopsy Major Product Offerings
7.11.4 OraSure Technologies Non-Invasive Liquid Biopsy Revenue in Global Market (2018-2023)
7.11.5 OraSure Technologies Key News & Latest Developments
7.12 PerkinElmer
7.12.1 PerkinElmer Company Summary
7.12.2 PerkinElmer Business Overview
7.12.3 PerkinElmer Non-Invasive Liquid Biopsy Major Product Offerings
7.12.4 PerkinElmer Non-Invasive Liquid Biopsy Revenue in Global Market (2018-2023)
7.12.5 PerkinElmer Key News & Latest Developments
7.13 Predicine
7.13.1 Predicine Company Summary
7.13.2 Predicine Business Overview
7.13.3 Predicine Non-Invasive Liquid Biopsy Major Product Offerings
7.13.4 Predicine Non-Invasive Liquid Biopsy Revenue in Global Market (2018-2023)
7.13.5 Predicine Key News & Latest Developments
7.14 Qiagen
7.14.1 Qiagen Company Summary
7.14.2 Qiagen Business Overview
7.14.3 Qiagen Non-Invasive Liquid Biopsy Major Product Offerings
7.14.4 Qiagen Non-Invasive Liquid Biopsy Revenue in Global Market (2018-2023)
7.14.5 Qiagen Key News & Latest Developments
7.15 Thermo Fisher Scientific
7.15.1 Thermo Fisher Scientific Company Summary
7.15.2 Thermo Fisher Scientific Business Overview
7.15.3 Thermo Fisher Scientific Non-Invasive Liquid Biopsy Major Product Offerings
7.15.4 Thermo Fisher Scientific Non-Invasive Liquid Biopsy Revenue in Global Market (2018-2023)
7.15.5 Thermo Fisher Scientific Key News & Latest Developments
7.16 Zymo Research Corporation
7.16.1 Zymo Research Corporation Company Summary
7.16.2 Zymo Research Corporation Business Overview
7.16.3 Zymo Research Corporation Non-Invasive Liquid Biopsy Major Product Offerings
7.16.4 Zymo Research Corporation Non-Invasive Liquid Biopsy Revenue in Global Market (2018-2023)
7.16.5 Zymo Research Corporation Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 非侵襲的リキッドバイオプシーの世界市場見通し2023年-2029年(Non-Invasive Liquid Biopsy Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。